BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10514906)

  • 1. Cytotoxic activity of Acinetobacter baumannii after treatment with aminoglycosides.
    Hostacká A; Kováciková Z
    Arzneimittelforschung; 1999 Sep; 49(9):770-2. PubMed ID: 10514906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amikacin on cytotoxic activity and hydrophobicity of Acinetobacter baumannii.
    Hostacká A; Kováciková Z
    Methods Find Exp Clin Pharmacol; 1999 Dec; 21(10):653-7. PubMed ID: 10702960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aminoglycosides on surface hydrophobicity of Acinetobacter baumannii.
    Hostacká A
    Acta Microbiol Immunol Hung; 2000; 47(1):15-20. PubMed ID: 10735186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum sensitivity and hydrophobicity in a clinical isolate of Klebsiella pneumoniae treated with subinhibitory concentrations of aminoglycosides.
    Hostacká A
    Zentralbl Bakteriol; 1998 Dec; 288(4):519-26. PubMed ID: 9987190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity of aminoglycosides against nosocomial strains of Acinetobacter baumannii isolated between 1990 and 1999].
    González G; Ramírez C; Muñoz M
    Rev Esp Quimioter; 2000 Dec; 13(4):401-4. PubMed ID: 11498707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
    Xirouchaki E; Giamarellou H
    J Chemother; 1992 Oct; 4(5):263-7. PubMed ID: 1479414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals.
    Cho YJ; Moon DC; Jin JS; Choi CH; Lee YC; Lee JC
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):185-90. PubMed ID: 19361944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread of novel aminoglycoside resistance gene aac(6')-Iad among Acinetobacter clinical isolates in Japan.
    Doi Y; Wachino J; Yamane K; Shibata N; Yagi T; Shibayama K; Kato H; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2075-80. PubMed ID: 15155202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacodynamic parameters of gentamicin and its effect on the surface hydrophobicity of Acinetobacter baumannii].
    Hostacká A
    Ceska Slov Farm; 2000 Jan; 49(1):41-4. PubMed ID: 10953442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
    Ygout JF; Pasteau C; Mugnier P; Berlioux J; Daguet GL
    Pathol Biol (Paris); 1988 Mar; 36(3):245-9. PubMed ID: 3283688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aminoglycoside resistance of Acinetobacter baumannii hospital strains in the Czech Republic].
    Nemec A; Maixnerová M
    Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):223-8. PubMed ID: 15558451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA; Seifert H; Appelbaum PC
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal meningitis with the presence of Acinetobacter spp.
    Gospodarek E; Kraśnicki K; Ziółkowski G; Kasprzak H; Beuth W
    Med Sci Monit; 2000; 6(1):50-4. PubMed ID: 11208283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
    Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J
    Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aminoside sensitivity of bacteria isolated in 1984 at the military hospital complex in the Paris region].
    Meyran M; Buisson Y; Saliou P; Levagueresse R; Santiago M; Thabaut A
    Pathol Biol (Paris); 1987 May; 35(5):457-60. PubMed ID: 3302847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.